Trials / Not Yet Recruiting
Not Yet RecruitingNCT07441200
Clinical Trial of NS-863 in Participants With Pulmonary Arterial Hypertension (PAH)
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose Finding Trial to Evaluate the Efficacy and Safety of Orally Administered NS-863 in Participants With Pulmonary Arterial Hypertension (PAH)
- Status
- Not Yet Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 135 (estimated)
- Sponsor
- NS Pharma, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose Finding Trial to Evaluate the Efficacy and Safety of Orally Administered NS-863 in Participants with Pulmonary Arterial Hypertension (PAH)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | NS-863 Low Dose | NS-863 is an orally administered drug |
| DRUG | NS-863 High Dose | NS-863 is an orally administered drug |
| DRUG | NS-863 Placebo | An orally administered NS-863 matching placebo |
Timeline
- Start date
- 2026-07-01
- Primary completion
- 2028-08-01
- Completion
- 2028-11-01
- First posted
- 2026-02-27
- Last updated
- 2026-02-27
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT07441200. Inclusion in this directory is not an endorsement.